<https://diabetesjournals.org/care/article/39/5/709/30854/Cardiovascular-and-Other-Outcomes-Postintervention>
<http://schema.org/description>
"OBJECTIVE. The Outcome Reduction With Initial Glargine Intervention (ORIGIN) trial reported neutral effects of insulin glargine on cardiovascular outcomes "
<https://diabetesjournals.org/care/article/39/5/709/30854/Cardiovascular-and-Other-Outcomes-Postintervention>